The Blood Industry

Published - Mar 2011| Analyst - Peggy Lehr| Code - HLC008G
Market Research Report Single User License: $2,750 Member Price: FREE

Report Highlights

The global blood market includes products used for collecting, typing, processing, and transfusing of blood and the sale of blood therapeutics. This market was worth $30 billion in 2010 and is forecast to increase at an 8.4% compound annual growth rate (CAGR) to reach $45 billion in 2015.

SCOPE OF REPORT

This report offers global and U.S. projections, by product segment, from 2010 through 2015, including supporting analyses for projections.  Product segments covered consist of blood and plasma collection, blood and plasma processing, blood therapeutic products, plasma therapeutic products, and emerging trends and products.

The arrangement of this report offers an overview of the key elements in the blood collection and processing businesses: blood typing techniques and markets, and plasma fractionation.  International markets are discussed, and information is provided on industry structure and the regulatory environment outside the U.S.

Profiles of more than 30 leading companies involved with blood collection, processing, and therapeutics are included.  The report provides information on company placement within the market and strategic analyses of the companies’ available and emerging products.

ANALYST CREDENTIALS

Peggy S. Lehr is the BCC Research analyst of this report.  Ms. Lehr has worked with the publishing arms of for-profit and nonprofit organizations for more than 30 years.  She specializes in marketing reports on the medical industry, and has contributed several reports on the medical industry for BCC.

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Note: Reports are discounted or included with certain Memberships. See Membership Options.
 
Published - Mar-2008| Analyst - Mary Anne Crandall| Code - HLC008F

Report Highlights

  • The U.S. blood market was worth $7.8 billion in 2007. It should reach $9.5 million by 2012, a compound annual growth rate (CAGR) of 5.7%.
  • Products used for collecting, processing and transfusing blood will grow from a $1.6 billion segment in 2007 to $2.2 billion by the end of the study period.
  • Major driving forces in the industry include the cost of collection and processing, and changes in the incidences of catastrophes requiring blood transfusions.
Published - Nov-2005| Analyst - Barbara Breindel| Code - HLC008E

Report Highlights

  • Sales for the blood and blood components segment and the plasma derived segment of the U.S. blood market will approach $6.6 billion in 2005 and are expected to approach $9.9 billion in 2010, rising at an average annual growth rate (AAGR) of 8.5%.
  • The collection and processing products segment will grow from over $1.8 billion to nearly $2.5 billion at an AAGR of 7%.
  • The driving forces of the industry are collection and processing cost, technology, an aging population and the changes in the incidence of diseases, surgical procedures and catastrophes that require transfusions.
  • Safety of the blood supply is the primary issue and donation testing has been enhanced with the greater use of nuclear amplifications testing methods.
Published - Aug-2001| Analyst - Cort Wrotnowski| Code - HLC008D

Report Highlights

  • The U.S. market for products used in the blood business are expected to exceed $6.1 billion in 2001.
  • The market is projected to reach nearly $8.7 billion by 2006, growing at an average annual rate (AAGR) of 7.2%.
  • The largest segment, blood components and plasma products, makes up over 80% of the market. Growing at an AAGR of 7.8% through 2005, these products will rise to command nearly 84% of the total market.
  • Equipment, blood tests and additional consumables will grow at an AAGR of 4.3% from $1.2 billion in 2001 to over $1.4 billion in 2006.

RELATED REPORTS
Share This Report